Glimepiride + Metformin + Pioglitazone

Akcell Biomedd offers a highly effective combination of Glimepiride + Metformin + Pioglitazone, specially formulated to provide powerful triple-action control for Type 2 Diabetes Mellitus. This advanced formulation helps maintain stable blood glucose levels in patients who require stronger glycemic management.

🔬 Triple Mechanism for Better Control

✔ Stimulates insulin secretion
✔ Reduces hepatic glucose production
✔ Improves insulin sensitivity in body tissues

This combination helps lower HbA1c levels and supports long-term diabetes management.

Why Choose This Product for PCD Franchise?

✅ High Market Demand in Diabetic Segment
✅ Attractive Packaging & Competitive Pricing
✅ High Prescribing Potential
✅ Better Profit Margins for Franchise Partners
✅ Promotional Support Available

The anti-diabetic segment is one of the fastest-growing therapeutic categories in India, making this product a profitable addition to your PCD portfolio.

Available Strengths

(You can mention strength like 1mg/500mg/15mg etc. as per your product)

Partner with Akcell Biomedd and expand your diabetic range with a trusted, high-demand formulation.

📞 Contact us today for PCD Franchise Opportunities.